Compare PBBK & SCNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PBBK | SCNX |
|---|---|---|
| Founded | 1919 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Banks | Other Pharmaceuticals |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 53.5M | 24.8M |
| IPO Year | N/A | 2020 |
| Metric | PBBK | SCNX |
|---|---|---|
| Price | $22.69 | $0.57 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 9.9K | ★ 1.7M |
| Earning Date | 10-23-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 53.39 | N/A |
| EPS | ★ 0.98 | N/A |
| Revenue | ★ $13,918,000.00 | $653,391.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $23.01 | ★ N/A |
| Revenue Growth | 17.20 | ★ 207.88 |
| 52 Week Low | $14.17 | $0.46 |
| 52 Week High | $22.92 | $8.19 |
| Indicator | PBBK | SCNX |
|---|---|---|
| Relative Strength Index (RSI) | 68.02 | 45.77 |
| Support Level | $22.10 | $0.54 |
| Resistance Level | $22.85 | $0.75 |
| Average True Range (ATR) | 0.40 | 0.06 |
| MACD | 0.04 | 0.00 |
| Stochastic Oscillator | 85.80 | 30.69 |
PB Bankshares Inc follows a community bank model and provides multiple services to individuals and small to midsize businesses. Its business consists of attracting retail and commercial deposits from the general public in its market area and investing those deposits, together with funds generated from operations and borrowings, in commercial real estate loans, commercial and industrial loans, construction, home equity lines of credit and to a lesser extent, one- to four-family residential real estate loans and consumer loans.
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on providing value to patients and caregivers by offering novel specialty products to satisfy unmet market needs and optimize the prescription journey and patient engagement in the U.S.